Zunveyl is a next-generation acetylcholinesterase inhibitor approved in the U.S. for mild-to-moderate Alzheimer's disease.

A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

Learn how targeted hip-opening exercises can boost flexibility, reduce chronic pain, and improve mobility patterns for better ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

Mild traumatic brain injury leads to reactivation of herpes simplex virus type 1, which may promote neurodegeneration and ...

As Lamborn prepares to leave office, we are most grateful for his support. His support of these signed bills advances the ...

CARES ID bracelets offer first responders the personal, contact and medical information of patients by quickly scanning a QR ...

Deidra Shubert from the Alzheimer's Association discusses healthy habits you can practice to keep your mind healthy in the new year. You can find those 10 healthy habits here. The Alzheimer's ...

After completing a study that spanned more than a decade, researchers have discovered a possible link between chronic pain ...

Cassava Sciences is laying off 10 employees —a third of its workforce—as the biotech seeks to conserve cash in the wake of ...

Empowering People in the Dementia Care Circle,” a free virtual series, will be offered through the Alzheimer’s Association and North Dakota State University Extension, beginning Jan. 22. The series of ...